AI assistant
DEXCOM INC — Director's Dealing 2016
Dec 20, 2016
30198_dirs_2016-12-20_22cead51-776e-46ec-b3fd-ceef7f2c3ca7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-12-09
Reporting Person: Murphy Patrick Michael (VP, Legal Aff & Chf Compl Ofcr)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 29128 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of DexCom, Inc. common stock.
F2: Included in this number are 29,128 unvested restricted stock units, 15,000 of which were granted on March 8, 2016 and shall vest 5,000 restricted stock units on March 8, 2017 and the remaining 10,000 restricted stock units shall vest over four equal installments on September 8, 2017, March 8, 2018, September 8, 2018 and March 8, 2019, 8,462 of which were granted on March 8, 2015 and 4,231 restricted stock units shall vest on each of March 8, 2017 and March 8, 2018, and 5,666 of which were granted on March 8, 2014 and shall vest on March 8, 2017.